Follow
Erik Mittra
Title
Cited by
Cited by
Year
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J Strosberg, G El-Haddad, E Wolin, A Hendifar, J Yao, B Chasen, E Mittra, ...
New England Journal of Medicine 376 (2), 125-135, 2017
27142017
A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle
MF Kircher, A De La Zerda, JV Jokerst, CL Zavaleta, PJ Kempen, E Mittra, ...
Nature medicine 18 (5), 829-834, 2012
11492012
Quantity and quality of trabecular bone in the femur are enhanced by a strongly anabolic, noninvasive mechanical intervention
C Rubin, AS Turner, R Müller, E Mittra, K McLeod, W Lin, YX Qin
Journal of bone and mineral research 17 (2), 349-357, 2002
4422002
US intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose–positron emission tomography imaging: Southwest …
OW Press, H Li, H Schöder, DJ Straus, CH Moskowitz, M LeBlanc, ...
Journal of Clinical Oncology 34 (17), 2020, 2016
2942016
Clinically approved nanoparticle imaging agents
AS Thakor, JV Jokerst, P Ghanouni, JL Campbell, E Mittra, SS Gambhir
Journal of Nuclear Medicine 57 (12), 1833-1837, 2016
2502016
Interrelationship of trabecular mechanical and microstructural properties in sheep trabecular bone
E Mittra, C Rubin, YX Qin
Journal of biomechanics 38 (6), 1229-1237, 2005
2402005
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long …
JR Strosberg, ME Caplin, PL Kunz, PB Ruszniewski, L Bodei, A Hendifar, ...
The Lancet Oncology 22 (12), 1752-1763, 2021
2222021
Prospective Evaluation of 99mTc MDP Scintigraphy, 18F NaF PET/CT, and 18F FDG PET/CT for Detection of Skeletal Metastases
A Iagaru, E Mittra, DW Dick, SS Gambhir
Molecular imaging and biology 14, 252-259, 2012
1692012
Pilot Pharmacokinetic and Dosimetric Studies of 18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3 Integrin Levels
ES Mittra, ML Goris, AH Iagaru, A Kardan, L Burton, R Berganos, E Chang, ...
Radiology 260 (1), 182-191, 2011
1512011
Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate for Imaging xC Transporter Using Positron Emission Tomography in Patients with Non …
S Baek, CM Choi, SH Ahn, JW Lee, G Gong, JS Ryu, SJ Oh, ...
Clinical cancer research 18 (19), 5427-5437, 2012
1372012
Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study
A Iagaru, E Mittra, SS Yaghoubi, DW Dick, A Quon, ML Goris, SS Gambhir
Journal of Nuclear Medicine 50 (4), 501-505, 2009
1262009
Neuroendocrine Tumor Therapy: 177Lu-DOTATATE
ES Mittra
American Journal of Roentgenology 211 (2), 278-285, 2018
1042018
Pulmonary ventilation imaging based on 4-dimensional computed tomography: comparison with pulmonary function tests and SPECT ventilation images
T Yamamoto, S Kabus, C Lorenz, E Mittra, JC Hong, M Chung, N Eclov, ...
International Journal of Radiation Oncology* Biology* Physics 90 (2), 414-422, 2014
1042014
Evaluation of trabecular mechanical and microstructural properties in human calcaneal bone of advanced age using mechanical testing, μCT, and DXA
E Mittra, C Rubin, B Gruber, YX Qin
Journal of Biomechanics 41 (2), 368-375, 2008
1012008
NANETS/SNMMI consensus statement on patient selection and appropriate use of 177Lu-DOTATATE peptide receptor radionuclide therapy
TA Hope, L Bodei, JA Chan, G El-Haddad, N Fidelman, PL Kunz, ...
Journal of Nuclear Medicine 61 (2), 222-227, 2020
962020
Positron emission tomography/computed tomography: the current technology and applications
E Mittra, A Quon
Radiologic Clinics of North America 47 (1), 147-160, 2009
942009
Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin–99mTc-sulfur colloid SPECT
MGEH Lam, ML Goris, AH Iagaru, ES Mittra, JD Louie, DY Sze
Journal of Nuclear Medicine 54 (12), 2055-2061, 2013
902013
Predicting response to immunotherapy by evaluating tumors, lymphoid cell-rich organs, and immune-related adverse events using FDG-PET/CT
T Nobashi, L Baratto, SA Reddy, S Srinivas, A Toriihara, N Hatami, ...
Clinical nuclear medicine 44 (4), e272-e279, 2019
862019
Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases
A Iagaru, P Young, E Mittra, DW Dick, R Herfkens, SS Gambhir
Clinical nuclear medicine 38 (7), e290-e296, 2013
862013
First Experience with Clinical-Grade [18F]FPP(RGD)2: An Automated Multi-step Radiosynthesis for Clinical PET Studies
FT Chin, B Shen, S Liu, RA Berganos, E Chang, E Mittra, X Chen, ...
Molecular Imaging and Biology 14, 88-95, 2012
842012
The system can't perform the operation now. Try again later.
Articles 1–20